Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of immortal time bias on the association between immune-related adverse events and oncological outcomes following immune checkpoint inhibitors therapy for head and neck squamous cell carcinoma.
Tamura K, Takenaka Y, Hosokawa K, Sato T, Tsuda T, Eguchi H, Suzuki M, Fukusumi T, Suzuki M, Inohara H. Tamura K, et al. PLoS One. 2024 Nov 25;19(11):e0314209. doi: 10.1371/journal.pone.0314209. eCollection 2024. PLoS One. 2024. PMID: 39585818 Free PMC article.
The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes.
Asahi K, Konta T, Tamura K, Tanaka F, Fukui A, Nakamura Y, Hirose J, Ohara K, Shijoh Y, Carter M, Meredith K, Harris J, Åkerborg Ö, Kashihara N, Yokoo T. Asahi K, et al. Among authors: tamura k. J Diabetes Investig. 2024 Nov 22. doi: 10.1111/jdi.14293. Online ahead of print. J Diabetes Investig. 2024. PMID: 39576736 Free article.
Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex).
Shimamoto S, Nakahara T, Yamada S, Nagasu H, Kishi S, Nakashima N, Tsuruya K, Okada H, Tamura K, Narita I, Maruyama S, Yano Y, Yokoo T, Wada T, Wada J, Kanda E, Kataoka H, Nangaku M, Kashihara N, Nakano T. Shimamoto S, et al. Among authors: tamura k. Sci Rep. 2024 Nov 11;14(1):27481. doi: 10.1038/s41598-024-79291-5. Sci Rep. 2024. PMID: 39523380 Free PMC article.
Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin.
Ishikawa G, Matsushita Y, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Watanabe S, Suzuki E, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Matsumoto R, Ito T, Nagata M, Unno T, Furuse H, Mizuno T, Otsuka A. Ishikawa G, et al. Among authors: tamura k. Cancer Diagn Progn. 2024 Nov 3;4(6):783-788. doi: 10.21873/cdp.10396. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502620 Free PMC article.
4,377 results